Delcath Systems Inc (DCTH)

0.0402 -0.00  -5.57% OTC Markets Dec 6, 10:47 Delayed 15m USD
View Full Chart
Price Chart
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.delcath.com
  • Investor Relations URL: http://delcath.com/investors/
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Medical Devices
  • Equity Style: Small Cap/Value
  • Next Earnings Release: N/A
  • Last Earnings Release: Aug. 08, 2018
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Delcath Systems Inc is a specialty pharmaceutical and medical device company. It is engaged in the development and commercialization of CHEMOSAT/Melphalan/HDS. The company focuses on the treatment of primary and metastatic liver cancers. Its investigational product Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.